Reclassifying HFmrEF as a stable phenotype aims to reduce therapeutic inertia and GDMT underuse driven by heterogeneous ...
A new peer-reviewed study led by Truveta and collaborators at Yale School of Medicine, Yale New Haven Hospital, and Duke University School of Medicine found that most patients with newly identified ...
USA: A cohort study highlighted a significant gap between evidence and real-world practice in patients with newly identified heart failure with reduced ejection fraction (HFrEF). Nearly two-thirds of ...
Patients with newly diagnosed heart failure with reduced ejection fraction (HFrEF) commonly have improvements in their LVEF, but that doesn’t mean they can let their guard down, data from a large ...
Withdrawing renin-angiotensin inhibitors/angiotensin receptor-neprilysin inhibitors and mineralocorticoid receptor antagonists tied to higher one-year mortality, morbidity. HealthDay News — In ...
The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure with left ventricular systolic dysfunction. For patients with ...
A research team from Cincinnati's Christ Hospital found that an AI virtual assistant improved outcomes for heart failure patients. A virtual assistant powered by artificial intelligence helped provide ...
A virtual assistant powered by artificial intelligence helped provide better treatment to heart failure patients than human caregivers alone, according to a new study from doctors at Cincinnati's ...